Hematology TimesNanocarriers could treat leukemia, lymphoma and improve HSCTSeptember 1, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationAggressive Lymphomas
Hematology TimesFDA warns about risk of death with pembrolizumab in MMSeptember 1, 2017Multiple Myeloma
Hematology TimesYoung cancer patients want more digital support, survey saysSeptember 1, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Hematology NewsFDA alert: pembrolizumab ups mortality risk in multiple myelomaAugust 31, 2017Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology TimesFDA approves first CAR T-cell therapy to treat ALLAugust 31, 2017Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesFDA approves drug to treat CRS induced by CAR T-cell therapyAugust 31, 2017Leukemia, Myelodysplasia, TransplantationALL
Oncology PracticeFocus on lifestyle to manage menopause symptoms after breast cancerAugust 30, 2017Breast CancerPatient & Survivor Care
Hematology NewsYoung adults lead the ranks of recently insuredAugust 30, 2017Business of MedicinePractice Management
Oncology PracticeTivozanib gets EU approval for advanced RCCAugust 30, 2017Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeFive outside-the-box ideas for fixing the individual insurance marketAugust 30, 2017Practice ManagementBusiness of Medicine
Oncology PracticeFDA expands approval of fulvestrant for HR+/HER2– advanced breast cancerAugust 30, 2017Breast Cancer
Hematology NewsFDA approves first gene therapy – tisagenlecleucel for ALLAugust 30, 2017ALLLeukemia, Myelodysplasia, TransplantationPediatricsImmuno-oncology
Hematology NewsVIDEO: Clopidogrel bests ticagrelor in PCI for ACS in real-world studyAugust 30, 2017Thrombosis
Oncology PracticeLow malignant potential tumors of the ovary: A reviewAugust 30, 2017Gynecologic Cancer
